H. Sanati et al., COMBINATION THERAPY WITH AMPHOTERICIN-B AND FLUCONAZOLE AGAINST INVASIVE CANDIDIASIS IN NEUTROPENIC-MOUSE AND INFECTIVE-ENDOCARDITIS RABBITMODELS, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1345-1348
Although there are an increasing number of new antifungal agents avail
able, the morbidity and mortality due to invasive mycoses remain high,
The high rates of polyene toxicities and the development of azole res
istance have raised the issue of using antifungal agents of these clas
ses in combination, despite theoretical concerns regarding antagonism
between such agents. This study,vas designed to evaluate the in vivo e
fficacy of combined therapy with amphotericin B and fluconazole agains
t Candida albicans, Two distinct animal models were used in this study
: a neutropenic-mouse model of hematogenously disseminated candidiasis
and the infective-endocarditis rabbit model, Treatment efficacy was a
ssessed by determining reductions in mortality as well as decreases in
tissue fungal densities, In the neutropenic-mouse model, amphotericin
B, as well as combination therapy, significantly prolonged survival c
ompared to untreated controls (P < 10(-5) and P = 0.001, respectively)
, The fungal densities in the kidneys of neutropenic mice were signifi
cantly reduced with either amphotericin B monotherapy or amphotericin
B-fluconazole combined therapy compared to those of controls (P < 10(-
6)), Fluconazole monotherapy also reduced fungal densities in the kidn
eys; however, this decrease was not statistically significant (P = 0.1
7), In contrast, treatment with either fluconazole alone or combined w
ith amphotericin B (but not amphotericin B monotherapy) significantly
decreased fungal densities in the brain (P = 0.025), In the rabbit end
ocarditis model, amphotericin B monotherapy or combined therapy signif
icantly decreased fungal densities in cardiac vegetations (P < 0.01 ve
rsus the controls). Although no significant antagonism was seen when f
luconazole was given in combination with amphotericin B, combination t
herapy did not augment the antifungal activity of amphotericin B.